- Home
- CALX vs CERT Comparison
CALX vs CERT Comparison
Compare CALX & CERT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CALX
- CERT
- Stock Information
- Founded
- CALX 1999
- CERT 2008
- Country
- CALX United States
- CERT United States
- Employees
- CALX N/A
- CERT N/A
- Industry
- CALX Telecommunications Equipment
- CERT Retail: Computer Software & Peripheral Equipment
- Sector
- CALX Consumer Discretionary
- CERT Technology
- Exchange
- CALX Nasdaq
- CERT Nasdaq
- Market Cap
- CALX 2.1B
- CERT 1.9B
- IPO Year
- CALX 2010
- CERT 2020
- Fundamental
- Price
- CALX $36.14
- CERT $11.60
- Analyst Decision
- CALX Strong Buy
- CERT Buy
- Analyst Count
- CALX 6
- CERT 7
- Target Price
- CALX $42.50
- CERT $15.92
- AVG Volume (30 Days)
- CALX 848.5K
- CERT 1.3M
- Earning Date
- CALX 01-27-2025
- CERT 11-06-2024
- Dividend Yield
- CALX N/A
- CERT N/A
- EPS Growth
- CALX N/A
- CERT N/A
- EPS
- CALX N/A
- CERT N/A
- Revenue
- CALX $890,128,000.00
- CERT $372,797,000.00
- Revenue This Year
- CALX N/A
- CERT $10.20
- Revenue Next Year
- CALX $3.13
- CERT $10.43
- P/E Ratio
- CALX N/A
- CERT N/A
- Revenue Growth
- CALX N/A
- CERT 5.62
- 52 Week Low
- CALX $26.76
- CERT $9.41
- 52 Week High
- CALX $45.15
- CERT $19.87
- Technical
- Relative Strength Index (RSI)
- CALX 59.14
- CERT 55.62
- Support Level
- CALX $34.55
- CERT $11.05
- Resistance Level
- CALX $36.55
- CERT $11.83
- Average True Range (ATR)
- CALX 1.09
- CERT 0.50
- MACD
- CALX 0.41
- CERT 0.06
- Stochastic Oscillator
- CALX 89.12
- CERT 63.87
About CALX Calix Inc
Calix Inc develops, market and sell Calix cloud, systems and software platforms to enable service providers of all types and sizes to innovate and transform. The company's customers utilize the real-time data and insights from Calix platforms to simplify their business and deliver experiences that excite their subscribers. The resulting growth in subscriber acquisition, loyalty and revenue creates more value for their businesses and communities. The Company's revenue is principally derived in the United States and it also has its presence in Middle East & Africa, Europe, Asia Pacific and other markets.
About CERT Certara Inc.
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval and increase patient access to medicines. The company has its business presence in the Americas which is also it key revenue generating market, EMEA and Asia Pacific region.